Advance Quality Manager at Clairo

Holland, Michigan, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

NoVisa

Automotive, Electric VehiclesIndustries

Requirements

Bachelor’s degree in Electrical, Chemical, or related Engineering field
3+ years of automotive quality experience
Strong knowledge of IATF 16949, ISO 26262, APQP, and AIAG/VDA Core Tools
Ability to travel up to 35% and work in office/plant/lab environments
Preferred
CQE certification
ASPICE implementation experience
Proficiency with Minitab, PPAP, DVP&R, and simulation tools
Background in EV systems, electrochemistry, and battery testing

Responsibilities

Lead Advanced Quality Planning across the U.S. Automotive Business Unit
Drive PPAP standardization
Implement ASPICE
Provide cross-functional quality leadership to ensure flawless product launches
Collaborate with engineering, manufacturing, and suppliers to deliver safe and reliable EV components
Ensure compliance with industry standards, mitigate risks, and maintain customer satisfaction

Skills

IATF 16949

ISO 26262

APQP

AIAG/VDA Core Tools

PPAP

ASPICE

Minitab

DVP&R

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free